Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

Molecular Predictors of Lung Cancer Behavior. (SPORE)

Multiple Cancer Types

Disease Sites: Lung, Non Small Cell, Small Cell

Phase: N/A

Investigator: Maldonado, Fabien

NCTID: NCT00898313

Protocol No: VICCTHO0398

Learn More

Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus

Disease Sites: Not Available

Phase: N/A

Investigator: Engelhardt, Brian

NCTID: NCT03415139

Protocol No: VICCCTT1836

Learn More

Inherited CAncer REgistry (ICARE) Initiative

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Pal, Tuya

NCTID: NCT03231891

Protocol No: VICCMD1712

Learn More

Molecular Fingerprinting of Lung Cancer (SPORE)

Multiple Cancer Types

Disease Sites: Lung, Non Small Cell

Phase: N/A

Investigator: Grogan, Eric

NCTID: NCT00897117

Protocol No: VICCTHO0136

Learn More

Near Infrared Autofluorescence via PTeye for the Detection of Parathyroid Glands during Total Thyroid Surgery

Thyroid

This trial studies how well infrared autofluorescence via PTeye works in detecting parathyroid glands during total thyroid surgery. Located closely to the thyroid gland are the parathyroid glands, which are important organs that regulate calcium levels in the body. Thus, it is essential for a surgeon to correctly identify this structure when performing a thyroid surgery. PTeye may help surgeon to identify and preserve healthy parathyroid glands during surgery. By assisting the surgeon in correctly identifying parathyroid glands, this device may improve the quality of the operation performed on the patient.

Disease Sites: Thyroid

Phase: N/A

Investigator: Solorzano, Carmen

NCTID: NCT04281875

Protocol No: VICCHN2017

Learn More

Artificial Tears for the Reduction of Radioiodine Levels in the Nasolacrimal Duct System of Patients with Thyroid Carcinoma following Radioiodine Therapy

Thyroid

This phase II trial studies how well artificial tears works in reducing radioiodine levels in the nasolacrimal duct system in patients with thyroid carcinoma following radioiodine therapy. Radioactive iodine therapy for thyroid carcinoma has been associated with nasolacrimal duct obstruction. Artificial tears may dilute the amount of radioactive iodine in the tears of the eyes, thus decreasing uptake by the cells lining the nasolacrimal duct system.

Disease Sites: Thyroid

Phase: II

Investigator: Sobel, Rachel

NCTID: NCT04327999

Protocol No: VICCHN2018

Learn More